Has anyone heard news concerning the progress of Phase III clinincal trials for this BioMed stock? The street concensus is that this company is a strong buy, but its value is close to its low for the year. There really hasn't been any news for several months. I think DCRN is a keeper, but wish I had more timely information on it.Thanks
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat